Regencell Bioscience (RGC) has had the highest return since April 1, 2024 by a mid-cap US stock, returning 15,273.1%.
| ASSET | % RETURN |
|---|---|
Regencell Bioscience (RGC) | 15,273.13% |
Power Solutions International, Inc Common Stock (PSIX) | 4,079.57% |
QMMM Holdings Limited Ordinary Shares (QMMM) | 3,880% |
Quantum Computing (QUBT) | 1,687.38% |
D-Wave Quantum (QBTS) | 1,117.24% |
GeneDx (WGS) | 1,083.96% |
Innodata (INOD) | 1,067.73% |
CommScope (COMM) | 1,046.67% |
Uniqure (QURE) | 1,022.5% |
Eos Energy Enterprises (EOSE) | 940.18% |
Ondas (ONDS) | 687.76% |
Centrus Energy (LEU) | 645.72% |
Anbio Biotechnology Class A Ordinary Shares (NNNN) | 608.17% |
VNET Group Inc DRC (VNET) | 566.45% |
Verona Pharma PLC ADR (VRNA) | 560.74% |
Nuscale Power (SMR) | 519.62% |
Cidara Therapeutics (CDTX) | 491.11% |
Abivax SA American Depositary Shares (ABVX) | 489.58% |
Sezzle (SEZL) | 476.65% |
GDS (GDS) | 471.64% |
Argan (AGX) | 442.08% |
Dave (DAVE) | 440.54% |
Hesai Group American Depositary Share, each ADS represents one Class B ordinary share (HSAI) | 440.38% |
Applied Digital (APLD) | 439.76% |
SSR Mining (SSRM) | 437.89% |
Mid-cap stocks are treated as having a market cap between $2B and $10B.
